In November 2008, C&O participated in the cefditoren licensing meeting organized by Meiji, a leading food and drug company in Japan, held in Tokyo, Japan. C&O has been Meiji’s designated distributor since January 2008 for the sale of its new generation cephalosporin, Meiact, in China.
Address5/F, Jihao Building, 1086 Shennan East Road, Luohu District, Shenzhen
Adverse drug reactions / Event feedback hotline025-6816 1304
Adverse drug reactions / Event feedback mail[email protected]
Official WeChat account Mobile page